Ultralife (ULBI) Current Deferred Revenue (2010 - 2012)

Ultralife's Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $1.9 million for Q4 2012.

• On a quarterly basis, Current Deferred Revenue rose 3.64% year-over-year to $1.9 million in Q4 2012; TTM through Dec 2012 was $1.9 million, a 3.64% increase from a year earlier, with the FY2012 full-year figure at $1.9 million, up 3.64% from the prior year.
• Current Deferred Revenue advanced to $1.9 million in Q4 2012 per ULBI's latest filing, from $1.8 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $2.9 million in Q4 2010 and bottomed at $1.8 million in Q4 2011.
• The 3-year median for Current Deferred Revenue is $1.9 million (2012), against an average of $2.2 million.
• Across the five-year window, Current Deferred Revenue tumbled 38.14% in 2011 and rose 3.64% in 2012, its largest moves.
• Year by year, Current Deferred Revenue stood at $2.9 million in 2010, then tumbled by 38.14% to $1.8 million in 2011, then grew by 3.64% to $1.9 million in 2012.
• Per Business Quant, the three latest ULBI Current Deferred Revenue figures stand at $1.9 million (Q4 2012), $1.8 million (Q4 2011), and $2.9 million (Q4 2010).